Orion Oyj (OTCMKTS:ORINY - Get Free Report)'s share price hit a new 52-week low on Monday . The company traded as low as $18.00 and last traded at $18.00, with a volume of 31 shares trading hands. The stock had previously closed at $18.00.
Orion Oyj Stock Performance
The company has a fifty day moving average of $20.06 and a 200-day moving average of $20.29. The company has a current ratio of 3.10, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $5.08 billion, a price-to-earnings ratio of 21.43 and a beta of 0.23.
Orion Oyj (OTCMKTS:ORINY - Get Free Report) last issued its quarterly earnings results on Tuesday, February 13th. The company reported $0.29 earnings per share (EPS) for the quarter. Orion Oyj had a return on equity of 27.75% and a net margin of 18.21%. The firm had revenue of $345.76 million for the quarter. As a group, equities research analysts anticipate that Orion Oyj will post 0.89 earnings per share for the current fiscal year.
About Orion Oyj
(
Get Free Report)
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Orion Oyj, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Orion Oyj wasn't on the list.
While Orion Oyj currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.
Get This Free Report
